Sanofi ADR (SNY) is a Healthcare · Drug Manufacturers - General company listed on NASDAQ. Price $42.48 (-1.53%), Market cap $112.08B, P/E ratio 20.16, 52-week low–high $43.60 ~ $55.44.
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targetin
Financial statements, price targets, institutional (13F) holdings and related news for Sanofi ADR are updated in real time on BlackAll Trade.
Sanofi ADR trades at $42.48 (-1.53%). Real-time quotes and charts are available on BlackAll Trade.
Sanofi ADR has a market cap of about $112.08B. Its P/E ratio is 20.16.
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It als